Intrasense announces a new European patent, for invention of a technology facilitating clinician's diagnostic work-up.
Intrasense announces the signature at RSNA of two contracts in the USA and one in the Middle East.
Intrasense announces its presence at RSNA 2016 where it will unveil its new Myrian® 2.0 version.
Intrasense announces its half-year results until June, 30 2016 as approved by the Board of Directors on October 24, 2016.